Childhood Brain Cancer: New Molecular Target Found
A new understanding of how “Frankengene” fusions drive rare, aggressive brain tumors in children is emerging from research at Fred Hutch Cancer Center, offering a potential pathway to targeted therapies for a disease that currently relies heavily on surgery and radiation – treatments with limited efficacy. This breakthrough isn’t just about a single tumor type; … Read more
